These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 22630616

  • 1. A pilot randomised controlled trial of modafinil during acute methamphetamine withdrawal: feasibility, tolerability and clinical outcomes.
    Lee N, Pennay A, Hester R, McKetin R, Nielsen S, Ferris J.
    Drug Alcohol Rev; 2013 Jan; 32(1):88-95. PubMed ID: 22630616
    [Abstract] [Full Text] [Related]

  • 2. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual.
    McGregor C, Srisurapanont M, Mitchell A, Wickes W, White JM.
    J Subst Abuse Treat; 2008 Oct; 35(3):334-42. PubMed ID: 18329221
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J, Darke S, Rodgers C, Slade T, van Beek I, Lewis J, Brady D, McKetin R, Mattick RP, Wodak A.
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [Abstract] [Full Text] [Related]

  • 4. The effects of modafinil treatment on neuropsychological and attentional bias performance during 7-day inpatient withdrawal from methamphetamine dependence.
    Hester R, Lee N, Pennay A, Nielsen S, Ferris J.
    Exp Clin Psychopharmacol; 2010 Dec; 18(6):489-97. PubMed ID: 21186923
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
    Longo M, Wickes W, Smout M, Harrison S, Cahill S, White JM.
    Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
    [Abstract] [Full Text] [Related]

  • 6. Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.
    Heinzerling KG, Swanson AN, Kim S, Cederblom L, Moe A, Ling W, Shoptaw S.
    Drug Alcohol Depend; 2010 Jun 01; 109(1-3):20-9. PubMed ID: 20092966
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP.
    Neuropsychopharmacology; 2005 Jan 01; 30(1):205-11. PubMed ID: 15525998
    [Abstract] [Full Text] [Related]

  • 8. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC, Montebello ME, Dyer KR, Quigley A, Blaszczyk J, Tomkins S, Shand D.
    Drug Alcohol Rev; 2008 May 01; 27(3):326-33. PubMed ID: 18368615
    [Abstract] [Full Text] [Related]

  • 9. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J, Razeghian Jahromi L.
    Trials; 2017 Jun 06; 18(1):259. PubMed ID: 28587620
    [Abstract] [Full Text] [Related]

  • 10. Acute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteers.
    Mahoney JJ, Jackson BJ, Kalechstein AD, De La Garza R, Chang LC, Newton TF.
    Int J Neuropsychopharmacol; 2012 Oct 06; 15(9):1241-9. PubMed ID: 22214752
    [Abstract] [Full Text] [Related]

  • 11. Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal.
    Acheson LS, Ezard N, Lintzeris N, Dunlop A, Brett J, Rodgers C, Gill A, Christmass M, McKetin R, Farrell M, Shoptaw S, Siefried KJ.
    PLoS One; 2022 Oct 06; 17(10):e0275371. PubMed ID: 36190973
    [Abstract] [Full Text] [Related]

  • 12. The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study.
    Mousavi SG, Sharbafchi MR, Salehi M, Peykanpour M, Karimian Sichani N, Maracy M.
    Arch Iran Med; 2015 Jan 06; 18(1):28-33. PubMed ID: 25556383
    [Abstract] [Full Text] [Related]

  • 13. Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial.
    Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, Gamble G, Hardley P, Jensen M, Kuoppasalmi K, Tuomola P, Föhr J, Kuikanmäki O, Vorma H, Salokangas R, Mikkonen A, Kallio M, Kauhanen J, Kiviniemi V, Tiihonen J.
    Addiction; 2013 Jul 06; 108(7):1279-86. PubMed ID: 23297867
    [Abstract] [Full Text] [Related]

  • 14. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J, Sahraian A, Biuseh M.
    Trials; 2019 Jul 30; 20(1):468. PubMed ID: 31362784
    [Abstract] [Full Text] [Related]

  • 15. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D, Chevret S, Quera-Salva MA, Laforêt P, Lofaso F, Verschueren A, Pouget J, Eymard B, Annane D.
    Clin Ther; 2009 Aug 30; 31(8):1765-73. PubMed ID: 19808135
    [Abstract] [Full Text] [Related]

  • 16. A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence.
    McKetin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, Dietze P, Carter G, Higgs P, Baker AL, Sinclair B, Reid D, Manning V, Te Pas N, Liang W, Thomas T, Bathish R, Kent M, Raftery D, Arunogiri S, Cordaro F, Hill H, Berk M.
    Trials; 2019 Jun 04; 20(1):325. PubMed ID: 31164169
    [Abstract] [Full Text] [Related]

  • 17. Modafinil: a second look. Confirmed efficacy in narcolepsy.
    Prescrire Int; 1999 Feb 04; 8(39):5-7. PubMed ID: 10557564
    [Abstract] [Full Text] [Related]

  • 18. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan 04; 43(1):88-97. PubMed ID: 9450772
    [Abstract] [Full Text] [Related]

  • 19. Modafinil for the treatment of methamphetamine dependence.
    Anderson AL, Li SH, Biswas K, McSherry F, Holmes T, Iturriaga E, Kahn R, Chiang N, Beresford T, Campbell J, Haning W, Mawhinney J, McCann M, Rawson R, Stock C, Weis D, Yu E, Elkashef AM.
    Drug Alcohol Depend; 2012 Jan 01; 120(1-3):135-41. PubMed ID: 21840138
    [Abstract] [Full Text] [Related]

  • 20. Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial.
    Acheson LS, Ezard N, Lintzeris N, Dunlop A, Brett J, Rodgers C, Gill A, Christmass M, McKetin R, Farrell M, Shoptaw S, Siefried KJ.
    Drug Alcohol Depend; 2022 Dec 01; 241():109692. PubMed ID: 36399936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.